Sebia Labordiagnostische Systeme GmbH, based in Mainz, is one of the leading developers and manufacturers of medical devices for clinical chemistry, autoimmune diagnostics and electrophoresis. Sebia has established itself as a strong brand in the field of in-vitro diagnostics for many years. The premium product portfolio includes laboratory equipment and reagents for the fields of oncology, metabolic diseases, genetic diseases, FLC and autoimmune diseases.

The company’s mission is to improve the healthcare of patients by providing high-quality products to healthcare professionals for precise diagnosis.

The company employs around 80 people and serves Sebia GmbH customers in Germany, Austria and Switzerland.

The Sebia parent company is based in France, near Paris, and has a total of 21 branches worldwide. The group of companies includes the subsidiaries ORGENTEC Diagnostika GmbH based in Mainz, Interlab Srl in Rome and Zeus Scientific in the USA.

Waclaw Lukowicz takes over the management of Sebia Labordiagnostische Systeme GmbH.